news & events
PET Imaging: A powerful tool for the Immune-Image project
Positron Emission Tomography (PET), is a powerful imaging technique that allows researchers to study the activity of cells and tissues within the body. This imaging modality has been widely used in the medical field to diagnose and monitor a variety of diseases,...
Immune-Image explores a new strategy for imaging CAR-T Cells
CAR-T cells, or chimeric antigen receptor T cells, are a type of immunotherapy that has shown great success in treating a subset of blood cancers. In this therapy, the patient’s own cells are genetically modified to recognize and target specific proteins on cancer...
Interview Andreas Jacobs – Leader work package 5
Andreas Jacobs from the University of Münster is leading work package 5 of the Immune-Image project together with Michael Schäfers of the Univerity of Münster and Ian Wilson of ImaginAb. In this work package they research the implementation of immunotracers for...
Meet the partner: ttopstart
Sigrid van Dorp is working as a consultant at ttopstart and has a background in public health and healthcare management. Within the Immune-Image project, ttopstart is part of work package 1 which focuses on management, coordination, dissemination and sustainability....
Researchers of Immune-Image reported about their recent scientific findings at EMIM2023 in Salzburg
EMIM 2023 On 14-17 March the 18th European Molecular Imaging Meeting (EMIM) took place in the heart of Salzburg, the city of Mozart. The focus was on quantification in molecular imaging, cellular imaging, x-ray/lung imaging, neuroimaging, and hyperpolarized MRI....
18th European Molecular Imaging Meeting (EMIM) in Salzburg
EMIM 2023 From 14-17 March the 18th European Molecular Imaging Meeting (EMIM) will take place in the world-famous Mirabell park gardens in the heart of Salzburg, the city of Mozart. The focus will be on quantification in molecular imaging, cellular imaging, x-ray/lung...
The Immune-Image activities of 2022 in a nutshell
At Immune-Image we haven’t sit still! Here in a nutshell what the Immune-Image project has done in 2022.
Interview Manfred Kneilling
Manfred Kneilling from the University of Tübingen is leading work package 4 of the Immune-Image project together with Bastian Zinnhardt from Roche. In this work package they evaluate the specificity and suitability of new immunotracers targeting different immune cells...
Meet the patient: Tom van der Wal
We interviewed Tom van der Wal from The Netherlands about his experiences with immunotherapy. Tom has Multiple Myeloma (Kahler) and was diagnosed in 2016, treated in VUmc Amsterdam, and was in remission in 2017. Unfortunately, the Multiple Myeloma returned in 2021. We...
Meet the partner: University of Cambridge
Kevin Brindle is Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a Senior Group Leader in the Cancer Research UK Cambridge Institute. The current focus of his work is to develop novel imaging methods to...
Immune-Image present at the European Molecular Imaging Meeting in Thessaloniki
On Thursday the 17th of March Immune-Image hosted a session at the 17th European Molecular Imaging Meeting (EMIM) in Thessaloniki. The session focused on Immuno-Therapy Imaging and was a great success. About the Immuno-Therapy Imaging focus session The focus...
Workshop Immuno-Imaging and Molecular Therapy
From 25th until the 29th of April the Medical Imaging Research Group of the Vrije Universiteit Brussel (VUB) in Belgium organizes a workshop, with support from the EU-funded Immune-Image consortium. The workshop ‘Immuno-Imaging and Molecular Therapy’ aims to bring...
Meet the person behind the researcher: Claudia Foray
Claudia Foray is a researcher for the Immune-Image project and is involved in the project because of the focus of her PhD project. In her research she tries to understand therapy-induced modification of the tumor microenvironment in glioma models using molecular...
Meet the partner: Lygature
Within Immune-Image, Lygature co-leads the data management work package, WP2, taking overall responsibility for the timely delivery of the deliverables and milestones in the various subtasks and the creation and execution of the data management plan. It is Lygature's...
Patient interview: Seamus Cotter
We interviewed Seamus Cotter from Ireland about his experiences with immunotherapy. Seamus has stage IV NSCLC lung cancer, was diagnosed in June 2016, and is now in remission. We asked him how he found out about immunotherapy, which treatment he received, and what his...
Interview Conny van der Laken
Conny van der Laken is a rheumatologist and a principal investigator of advanced imaging studies in rheumatology at the University of Amsterdam. Within the Immune-Image project, she is leader of Task 6.5, in a work package linked to patient research. Her research...
Immune-Image 2nd annual meeting 27, 28, 29 September
Two years after the start date of the Immune Image project its second annual meeting will be held. The Immune-Image consortium consists of 22 partner institutes and over 125 scientists key players from across 9 countries. Collectively they bring extensive expertise,...
”Imaging a particular immune cell subpopulation, that is the holy grail”
Professor Nick Devoogdt is, together with Wouter Driessen of Roche, leader of work package 3 of the Immune-Image project. In this work package their team develops new immunotracers for cancer and inflammatory diseases by imaging specific immune cells. We interviewed...
”Within Immune-Image we actually want to deliver new immunotracers to the patients”
Natascha Stergiou is a researcher (postdoc) for the Immune-Image project in work package 3 and is developing a universal and inert labeling protocol for immune cells which will be used in cancer therapy. The unique strategy in this project is to radiolabel the immune...
Meet our partner: Kevin Maresca from Pfizer
Kevin Maresca works in Early Clinical Development within Pfizer’s Worldwide Research, Development and Medical (WRDM) organization. He is head of PET/Molecular Imaging within the Digital Medicine and Translational Imaging group. We talked with Kevin about the role of...
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831514. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
